GTXI
$0.90
GTX
($.04)
(4.26%)
GTXI
Earnings Whisper ®
N/A
4th Quarter December 2018
Consensus:  ($0.22)
Revenue:  N/A
Monday
Mar 11
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when GTXI reports earnings?
Beat
Meet
Miss

Where is GTXI's stock price going from here?
Up
Flat
Down
Stock chart of GTXI
Analysts
Summary of analysts' recommendations for GTXI
Score
Grade
Pivots
Resistance
$1.01
$0.99
$0.97

$0.95

Support
$0.92
$0.90
$0.88
Tweet
Growth
Description
GTX Inc is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutics primarily related to the treatment of serious men's health conditions. GTx's drug discovery and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens.
Peers
BioMarin PharmaceuticalVertex PharmaceuticalsRegeneron PharmaceuticalsCelgeneInterCeptMylanUltragenyx PharmaceuticalEndo International plcJohnson & JohnsonPerrigo